The Senate Appropriations Committee held a hearing on Wednesday with bipartisan support to address the Trump administration’s cuts to federally funded biomedical research. Senator Susan Collins, the Republican chair of the committee, criticized the administration for reducing funding, cancelling grants, and laying off federal health department employees. She emphasized the importance of reversing these changes to maintain America’s global leadership in innovation.
Collins expressed concern about the proposed funding cuts, the dismissal of essential federal scientists, and the uncertainties in policy that could undermine the foundation of biomedical research in the country. The hearing, titled “Biomedical Research: Keeping America’s Edge in Innovation,” brought attention to the critical need for continued investment in research and development to support scientific advancements and medical breakthroughs.
However, access to the full article is restricted to STAT+ subscribers. The article highlights the exclusive insights on Capitol Hill and the life sciences industry that subscribers can access. To unlock the full content and daily intelligence, readers are encouraged to subscribe to STAT+ for a comprehensive understanding of the latest developments in biomedical research and healthcare.
The message emphasizes the value of subscribing to STAT+ to gain access to in-depth analysis and coverage of important issues in the field of biomedicine. By subscribing, readers can stay informed about the latest trends, policies, and breakthroughs in biomedical research, ensuring they are up-to-date with the evolving landscape of healthcare and innovation.
In conclusion, the Senate hearing underscored the bipartisan support for reversing the cuts to federally funded biomedical research and highlighted the critical role of innovation in advancing healthcare. Subscribing to STAT+ provides readers with exclusive access to in-depth articles and daily intelligence on key developments in the life sciences industry, empowering them to stay informed and engaged in the world of biomedical research.
